ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed

Xing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-8215-8000; OpenAlex author ID A5100399164. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling. Co-author DOI 10.3892/or.2018.6241 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bicheng Chen · 1 shared paper, 2018 · strength 0.09
- Paper Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3… DOI 10.3892/or.2018.6241 ↗
Mengtao Zhou · 1 shared paper, 2018 · strength 0.09
- Paper Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3… DOI 10.3892/or.2018.6241 ↗
Yongheng Bai · 1 shared paper, 2018 · strength 0.09
- Paper Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3… DOI 10.3892/or.2018.6241 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.